Deon Nicholas logo

Deon Nicholas

North America, California, United States

Description

Deon is the Founder and CEO of Forethought. He attended the University of Waterloo.

Investor Profile

Deon Nicholas has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Deon Nicholas frequently co-invest with?

Arkitekt Ventures
North America, New York, United States, New York
Co-Investments: 1
Boost VC
North America, California, United States, San Mateo
Co-Investments: 1
SV Angel
North America, California, United States, San Francisco
Co-Investments: 1
Lux Capital
North America, New York, United States, New York
Co-Investments: 1
Maverick Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Village Global
North America, California, United States, Covina
Co-Investments: 1
Threshold
North America, California, United States, Menlo Park
Co-Investments: 1

Which angels does Deon Nicholas often collaborate with?

CH
North America, Nevada, United States, Reno
Shared Deals: 1
AZ
North America, California, United States, San Francisco
Shared Deals: 1
DB
North America, California, United States, San Francisco
Shared Deals: 1
AY
North America, District of Columbia, United States, Washington
Shared Deals: 1
BT
North America, California, United States, San Francisco
Shared Deals: 1
CM
North America, California, United States, San Francisco
Shared Deals: 1
EC
North America, California, United States, San Francisco
Shared Deals: 1
AD
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
Shared Deals: 1
Alyssa Atkins
North America, Ontario, Canada, Toronto
Shared Deals: 1

What are some of recent deals done by Deon Nicholas?

HumanFirst

San Francisco, California, United States

HumanFirst accelerates the adoption of patient-centered clinical trials using precision digital measures (e.g., digital biomarkers and eCOA)

Health Care
Series AMay 31, 2021
Amount Raised: $12,000,000